Form 3 Filing - Decoy Therapeutics Inc.
2026-07-31SEC Filing 3 (0001193125-26-328787)
This filing is an initial report of beneficial ownership on Form 3 for Patricia G. Gauthier, a director at Decoy Therapeutics Inc. The filing indicates that no securities are beneficially owned by Ms. Gauthier as of the reporting date. The document also includes an exhibit which is a Power of Attorney. This Power of Attorney designates Mark Rosenblum and Annie Yan as attorneys-in-fact to execute and file necessary documents with the SEC, including Forms 3, 4, and 5, and Schedules 13D and 13G, related to the Securities Exchange Act of 1934 and Rule 144 of the Securities Act of 1933. The attorneys-in-fact are also empowered to manage the undersigned's EDGAR account.
Ticker mentioned:SLRX
Source:Original SEC Document β